Inventor · disambiguated record
Ming-Qiang Zhang
Also filed as: ZHANG MING · ZHANG MING QIANG
4 granted patents·8 pending applications·8 citations·filing 2003–2025
65Inventor score
Files withANTENGENE DISCOVERY LTD2BIOTICA TECH LTD1GUIBLIN ALEXANDER R1MOSS STEVEN1VERTEX PHARMACEUTICALS CANADA INC1
Top patents by PatentIndex Score
12 records- 0167US12312357B2PRMT5 inhibiting compounds and uses thereofANTENGENE DISCOVERY LTD·Filed 2024·Granted May 27, 2025·0 cites·3 claims
- 0267US7288548B2Spiro compounds and methods for the modulation of chemokine receptor activityVIROCHEM PHARMA INC·Filed 2004·Granted Oct 30, 2007·4 cites·40 claims
- 0362US7351713B2Spirohydantoin compounds and methods for the modulation of chemokine receptor activityVIRO CHEM PHARMA INC·Filed 2004·Granted Apr 1, 2008·4 cites·39 claims
- 0457US8829030B2Compounds and methods for the treatment or prevention of Flavivirus infectionsVERTEX PHARMACEUTICALS CANADA INC·Filed 2012·Granted Sep 9, 2014·0 cites·14 claims
- 0549US2025206749A1Prmt5 inhibiting compounds and uses thereofANTENGENE DISCOVERY LTD·Filed 2025·Application pending·0 cites
- 0646US2010210597A1C21-Deoxy Ansamycin Derivatives as Antitumor AgentsMOSS STEVEN·Filed 2008·Application pending·0 cites
- 0746US2009209572A136-Des(3-Methoxy-4-Hydroxycyclohexyl) 36-(3-Hydroxycycloheptyl) Derivatives of Rapamycin for the Treatment of Cancer and Other DisordersBIOTICA TECH LTD·Filed 2008·Application pending·0 cites
- 0845US2009312316A1Novel compoundsWILKINSON BARRIE·Filed 2007·Application pending·0 cites
- 0944US2005075326A1Spiro compounds and methods for the modulation of chemokine receptor activityFiled 2004·Application pending·0 cites
- 1042US2010279995A1Novel Ansamycin DerivativesGUIBLIN ALEXANDER R·Filed 2006·Application pending·0 cites
- 1141US2005176767A1Pyridine carboxamide and methods for inhibiting HIV integraseFiled 2004·Application pending·0 cites
- 1241US2004192707A1Compounds and methods for the treatment or prevention of Flavivirus infectionsFiled 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →